Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Absci Corp
ABSICurrent price
3.02 USD
-0.19 USD (-5.78%)
Last closed
3.14 USD
Company
www.absci.com
ISIN
US00091E1091
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
462 172 928 USD
Yield for 12 month
+115.36 %
1Y
3Y
5Y
10Y
15Y
ABSI
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington. Address: 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.29 USDP/E ratio
–Dividend Yield
–Current Year
+5 718 000 USD
Last Year
+5 747 000 USD
Current Quarter
+1 270 000 USD
Last Quarter
+898 000 USD
Current Year
-8 281 000 USD
Last Year
-7 290 000 USD
Current Quarter
-2 114 000 USD
Last Quarter
-2 518 000 USD
Key Figures ABSI
1 year
3 years
5 years
10 years
EBITDA
-83 964 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-23.98 %
PEG Ratio
–
Return On Equity TTM
-42.24 %
Wall Street Target Price
8.29 USD
Revenue TTM
3 250 000 USD
Book Value
1.95 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-62.3 %
Dividend Yield
–
Gross Profit TTM
-39 804 000 USD
Earnings per share
-0.93 USD
Diluted Eps TTM
-0.93 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ABSI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ABSI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ABSI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
102.1427
Price Sales TTM
142.2071
Enterprise Value EBITDA
-0.3911
Price Book MRQ
2.0944
Financials ABSI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ABSI
For 52 weeks
1.28 USD
6.72 USD
50 Day MA
3.99 USD
Shares Short Prior Month
13 343 673
200 Day MA
4.37 USD
Short Ratio
16.88
Shares Short
13 222 917
Short Percent
17.25 %
BeatStart